Jump to content

Biocrystallization

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by TimVickers (talk | contribs) at 04:30, 5 May 2008 (expand summary). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Biocrystallization is the formation of crystals by living organisms. This may be a stress response, or a normal part of metabolism such as processes that dispose of waste compounds. Inhibitors of biocrystallization are of interest in drug design efforts against pathogens that feed on blood, since many of these organisms use this process to safely dispose of haem.

DNA

Under severe stress conditions the bacteria Escherichia coli protects its DNA from damage by sequestering it within a crystalline structure.[1] This process is mediated by the stress response protein Dps and allows the bacteria to survive varied assaults such as oxidative stress, heat shock, ultraviolet light, gamma radiation and extremes of pH.[2][3]

Heme

Blood feeding organisms digest hemoglobin and release high quantities of free toxic heme. To avoid destruction by this molecule, the parasite biocrystallizes heme to form hemozoin.[4] To date, the only definitively characterized product of hematin is the pigment hemozoin. Heme biocrystallization has been found in blood feeding organisms of great medical importance including Plasmodium, Rhodnius and Schistosoma. Heme biocrystallization is inhibited by quinoline antimalarials, the biocrystallization inhibitor Chloroquine is one of the best antimicrobials ever developed.

References

  1. ^ Wolf SG, Frenkiel D, Arad T, Finkel SE, Kolter R, Minsky A (1999). "DNA protection by stress-induced biocrystallization". Nature. 400 (6739): 83–5. doi:10.1038/21918. PMID 10403254. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  2. ^ Nair S, Finkel SE (2004). "Dps protects cells against multiple stresses during stationary phase". J. Bacteriol. 186 (13): 4192–8. doi:10.1128/JB.186.13.4192-4198.2004. PMID 15205421. {{cite journal}}: Unknown parameter |month= ignored (help)
  3. ^ Frenkiel-krispin, D. (2002). "Biocrystallization: A last-resort survival strategy in bacteria". ASM News. 68 (6). Retrieved 2008-05-05. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  4. ^ Hempelmann E (2007). "Hemozoin biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors". Parasitol. Res. 100 (4): 671–6. doi:10.1007/s00436-006-0313-x. PMID 17111179. {{cite journal}}: Unknown parameter |month= ignored (help)